Maa: Irlanti
Kieli: englanti
Lähde: HPRA (Health Products Regulatory Authority)
RAMIPRIL
Sanofi-Aventis Ireland Limited
2.5 Milligram
Tablets
2005-05-13
IRISH MEDICINES BOARD ACTS 1995 AND 2006 MEDICINAL PRODUCTS(CONTROL OF PLACING ON THE MARKET)REGULATIONS,2007 (S.I. NO.540 OF 2007) PA0540/137/006 Case No: 2067911 The Irish Medicines Board in exercise of the powers conferred on it by the above mentioned Regulations hereby grants to SANOFI-AVENTIS IRELAND LIMITED CITYWEST BUSINESS CAMPUS, DUBLIN 24, IRELAND an authorisation, subject to the provisions of the said Regulations, in respect of the product RAMIPRIL 2.5MG TABLETS The particulars of which are set out in Part I and Part II of the attached Schedule. The authorisation is also subject to the general conditions as may be specified in the said Regulations as listed on the reverse of this document. This authorisation, unless previously revoked, shall continue in force from 24/07/2009 until 12/05/2010. Signed on behalf of the Irish Medicines Board this ________________ A person authorised in that behalf by the said Board. IRISH MEDICINES BOARD ________________________________________________________________________________________________________________________ _Date Printed 24/07/2009_ _CRN 2067911_ _page number: 1_ PART II SUMMARY OF PRODUCT CHARACTERISTICS 4 CLINICAL PARTICULARS 5 PHARMACOLOGICAL PROPERTIES 6 PHARMACEUTICAL PARTICULARS IRISH MEDICINES BOARD ________________________________________________________________________________________________________________________ _Date Printed 24/07/2009_ _CRN 2067911_ _page number: 2_ Lue koko asiakirja